Talk
Microbiome-based biomarker predicts response to immune checkpoint inhibitor therapy in a melanoma meta-cohort independently of clinical features
January 10, 2021
Multi-technology Meta-analysis Identifies Bacterial Signatures Delineating Clinical Response to Immune Checkpoint-Inhibitor Therapy in Melanoma Cohorts
November 9, 2019
Targeting the Inflammasome through P2X7 receptor, and its Potential Implications for NASH Therapy
October 21, 2019